In drug development, the majority of new chemical entities are lipophilic and/or poorly soluble. New actives often fail during development due to these challenging properties.
Dr Ralph Fink
Advertisement
Dr. Ralf Fink is Vice-President of Global Marketing, BASF Pharma Ingredients & Services.
Articles by Dr Ralph Fink
Advertisement
Latest Updated Articles
Collaborative Work can Lead to InnovationPublished: September 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5
